Alzheimer disease 1999: A status report

被引:17
作者
Kowall, NW
机构
[1] Edith Nourse Rogers Mem Vet Adm Hosp, Ctr Geriatr Res Educ & Clin, Bedford, MA 01730 USA
[2] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA
[3] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA
关键词
Alzheimer disease; beta amyloid; antioxidant; antiinflammatory; estrogen; caregiver;
D O I
10.1097/00002093-199904001-00005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Although the cause of Alzheimer disease (AD) remains a mystery, a great deal of progress has been made over the past 15 years. A large body of evidence suggests that beta amyloid (A beta) deposition and toxicity are critical steps leading to neuronal death in AD. Evidence is beginning to show that antioxidant and antiinflammatory drugs and estrogen may prevent, delay onset, or slow the progression of AD. Until a cure is found it will be necessary to provide high-quality long-term and palliative care in the community or in specialized treatment centers. The AD patient's caregiver often suffers in silence and research is needed to better understand disease burden to design appropriate interventions for these victims of AD.
引用
收藏
页码:S11 / S16
页数:6
相关论文
共 85 条
  • [61] ERAB contains a putative noncleavable signal peptide
    Sambamurti, K
    Lahiri, DK
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 249 (02) : 546 - 549
  • [62] A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease
    Sano, M
    Ernesto, C
    Thomas, RG
    Klauber, MR
    Schafer, K
    Grundman, M
    Woodbury, P
    Growdon, J
    Cotman, DW
    Pfeiffer, E
    Schneider, LS
    Thal, LJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (17) : 1216 - 1222
  • [63] Schneider LS, 1998, J CLIN PSYCHIAT, V59, P8
  • [64] Induced expression of neuronal membrane attack complex and cell death by Alzheimer's β-amyloid peptide
    Shen, Y
    Sullivan, T
    Lee, CM
    Meri, S
    Shiosaki, K
    Lin, CW
    [J]. BRAIN RESEARCH, 1998, 796 (1-2) : 187 - 197
  • [65] Progressive neuronal injury associated with amyloid plaque formation in Alzheimer disease
    Sheng, JG
    Zhou, XQ
    Mrak, RE
    Griffin, WST
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1998, 57 (07) : 714 - 717
  • [66] An economic evaluation of donepezil in the treatment of Alzheimer's disease
    Small, GW
    Donohue, JA
    Brooks, RL
    [J]. CLINICAL THERAPEUTICS, 1998, 20 (04) : 838 - 850
  • [67] Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress
    Smith, MA
    Hirai, K
    Hsiao, K
    Pappolla, MA
    Harris, PLR
    Siedlak, SL
    Tabaton, M
    Perry, G
    [J]. JOURNAL OF NEUROCHEMISTRY, 1998, 70 (05) : 2212 - 2215
  • [68] Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenylhydrazine
    Smith, MA
    Sayre, LM
    Anderson, VE
    Harris, PLR
    Beal, MF
    Kowall, N
    Perry, G
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1998, 46 (06) : 731 - 735
  • [69] Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of APOE
    Song, YQ
    Rogaeva, E
    Premkumar, S
    Brindle, N
    Kawarai, T
    Orlacchio, A
    Yu, G
    Levesque, G
    Nishimura, M
    Ikeda, M
    Pei, Y
    O'Toole, C
    Duara, R
    Barker, W
    Sorbi, S
    Freedman, M
    Farrer, L
    St George-Hyslop, P
    [J]. NEUROSCIENCE LETTERS, 1998, 250 (03) : 189 - 192
  • [70] Stewart A, 1998, INT J GERIATR PSYCH, V13, P445, DOI 10.1002/(SICI)1099-1166(199807)13:7<445::AID-GPS794>3.3.CO